Rajesh Malik Net Worth & Insider Trades

Rajesh Malik - Chief Medical Officer, G1 Therapeutics, Inc

As of July 6, 2022

What is Rajesh Malik's Net Worth?

The current estimated net worth of G1 Therapeutics, Inc's Chief Medical Officer, Rajesh Malik, is estimated to be about $3.46M . Rajesh Malik owns about 73,207 units of G1 Therapeutics, Inc common stock. In the last 4 years at G1 Therapeutics, Inc, Rajesh Malik has sold an estimated value of $3.34M worth.

What is Rajesh Malik's Past Insider Trading?

Rajesh Malik's largest purchase order was 15,000 units , worth over $62.55K on January 22, 2021. Rajesh Malik's largest sale order was 15,000 units , worth over $344.19K on March 4, 2021. In total, Rajesh Malik has made about 31 transactions over 4 years of their time at G1 Therapeutics, Inc. Rajesh Malik usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 648 units , worth over $3.35K on July 6, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Rajesh Malik's Salary in 2020?

As Chief Medical Officer of G1 Therapeutics, Inc, Rajesh Malik has a total base salary of $424,000 . Rajesh Malik received compensation valued at about $1,418,033 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of option awards of $836,733 , other earnings, plans or compensations of $148,750 , and other compensation of $8,550 .

What is Rajesh Malik's' Mailing Address?

  • Mailing address is 79 TW Alexander Drive 4501 Research Commons, Suite 100 Research Triangle Park NC 27709 NC

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

What are G1 Therapeutics, Inc's Past Insider Trades?

G1 Therapeutics, Inc's most recent insider trade came on July 6, 2022 by Terry Murdock who sold 648 units worth $3.35K . In the last 5 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $67.68M and bought an estimated value of $25.7M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO .

G1 Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1